Arianna Granese

Pubblicazioni

Titolo Pubblicato in Anno
Development of N-(4-(1 H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability JOURNAL OF MEDICINAL CHEMISTRY 2024
Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections EXPERT OPINION ON THERAPEUTIC PATENTS 2023
Synthesis and Evaluation of Thymol-Based Synthetic Derivatives as Dual-Action Inhibitors against Different Strains of H. pylori and AGS Cell Line MOLECULES 2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes ANTIOXIDANTS 2021
Phytochemical analyses and pharmacological screening of Neem oil SOUTH AFRICAN JOURNAL OF BOTANY 2019
Analytical procedures for secondary metabolites determination: recent trends and future perspectives LETTERS IN DRUG DESIGN & DISCOVERY 2018
Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2016
(Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2015
Bioactive compounds of Crocus sativus L. and their semisynthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2015
Nitric oxide donors and selective carbonic anhydrase inhibitors: A dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis MOLECULES 2015

ERC

  • LS1
  • LS7_4
  • PE4_2
  • PE4_5
  • PE5

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Sintesi di composti come inibori selettivi delle monoamminossidasi, MAO-A e MAO-B.

Sintesi di composti attivi sull'Helicobacter pylori, su ceppi di Candida e su Toxoplasma.

Sintesi di composti come inibitori/modulatori delle istone acetiltransferasi (HAT)

Keywords

anticancer agent
neuroprotective agents
drug design and discovery

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma